A high pressure build in late October, early November, has the potential of a similar path to Hurricane Helene.
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic ...
November. The post The Next Hurricane in the Gulf Could Form in These Two Places, Experts Say appeared first on Mandatory.
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with ...
The National Hurricane Center says that the broad area of low pressure is likely to develop over the southwestern Caribbean ...
Long-range computer forecasts are in much better agreement that a disturbance, tropical depression, or perhaps Tropical Storm ...
In trading on Friday, shares of Gyre Therapeutics Inc (Symbol: GYRE) crossed above their 200 day moving average of $14.43, changing hands as high as $14.83 per share. Gyre Therapeutics Inc shares ...
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...